Stock listing
ACOG Stock Price, News, Filings & Events — Alpha Cognition Inc.
Selected listing: ACOG · BOATS · USD · US
This page tracks Alpha Cognition Inc.'s ACOG:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACOG:BOATS. ACOG:BOATS is the stock-level entry point for investors researching Alpha Cognition Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alpha Cognition Inc. (Ticker: ACOG) is a public company operating in the American market, with a market capitalization of approximately $172 million. The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.

- Ticker
- ACOG:BOATS
- Asset type
- Stock
- Market cap
- $192.5M
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- BOATS
- Currency
- USD
Alpha Cognition Inc. ACOG:BOATS stock context
This page tracks Alpha Cognition Inc.'s ACOG:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ACOG:BOATS. ACOG:BOATS is the stock-level entry point for investors researching Alpha Cognition Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alpha Cognition Inc. (Ticker: ACOG) is a public company operating in the American market, with a market capitalization of approximately $172 million. The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.
Research Alpha Cognition Inc.
Alpha Cognition Inc. investor report
Review AI stock analysis and investor report context for ACOG:BOATS.
Alpha Cognition Inc. company profile
View the public company page for Alpha Cognition Inc. on 6ix.
Alpha Cognition Inc. news
Read company news and market updates connected to Alpha Cognition Inc..
Alpha Cognition Inc. investor events
Find investor webinars, events, and replay context for Alpha Cognition Inc..